MMRF And LLS Grant $500,000 For Study Of The Multiple Myeloma Stem Cell
The Multiple Myeloma Research Foundation (MMRF) and the Leukemia & Lymphoma Society (LLS) have paired up to fund a research initiative focusing on multiple myeloma cancer stem cells. Dr. William Matsui of Johns Hopkins University and Dr. Irving Weissman of Stanford University each received research grants worth $250,000.
After prominent cancer stem cell experts met at the 2008 MMRF Myeloma Cancer Stem Cell Research Roundtable, it was decided that myeloma cancer stem cells studies should be funded.
Some scientists believe that cancer stem cells, which are immature cancer cells, are responsible for the proliferation and reappearance of cancer.
Dr. Matsui studies myeloma stem cells, and Dr. Weissman studies the development of blood-forming cells. Their research will allow existing cancer stem cell information to be applied to multiple myeloma, and may help develop more treatment options.
For more information, please visit the Business Wire Web site.
Related Articles:
- Number And Type Of Stem Cell Transplants Carried Out Each Year For Multiple Myeloma Vary Markedly Across U.S. Cancer Centers
- Stem Cell Transplantation May Be Underutilized In Multiple Myeloma Patients In Their 80s
- Latest Myeloma Research To Be Presented At The American Society Of Clinical Oncology Annual Meeting (ASCO 2018)
- Revlimid, Velcade, and Dexamethasone, Followed By Stem Cell Transplantation, Yields Deep Responses And Considerable Overall Survival In Newly Diagnosed Multiple Myeloma
- Selective Digestive Decontamination May Reduce Risk of Infection In Myeloma Patients Undergoing Autologous Stem Cell Transplants